Cargando…
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors
The histone lysine methyltransferase DOT1L (DOT1-like histone lysine methyltransferase) is responsible for the epigenetic regulation of gene expression through specific methylation of lysine79 residue of histone H3 (H3K79) in actively transcribed genes. Its normal activity is crucial for embryonic d...
Autores principales: | Alexandrova, Elena, Salvati, Annamaria, Pecoraro, Giovanni, Lamberti, Jessica, Melone, Viola, Sellitto, Assunta, Rizzo, Francesca, Giurato, Giorgio, Tarallo, Roberta, Nassa, Giovanni, Weisz, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043692/ https://www.ncbi.nlm.nih.gov/pubmed/35495127 http://dx.doi.org/10.3389/fgene.2022.864612 |
Ejemplares similares
-
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer
por: Alexandrova, Elena, et al.
Publicado: (2022) -
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells
por: Salvati, Annamaria, et al.
Publicado: (2019) -
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer
por: Salvati, Annamaria, et al.
Publicado: (2022) -
An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
por: Alexandrova, Elena, et al.
Publicado: (2020) -
Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells
por: Nassa, Giovanni, et al.
Publicado: (2019)